Suven Life Science gets nod from US bankruptcy court to buy assets of Rising Pharmaceuticals

15 Apr 2019 Evaluate

Suven Life Science has received approval from a US bankruptcy court to buy assets of Rising Pharmaceuticals through its joint venture partner Shore Suven Pharma Inc. The company has completed a ‘stalking horse agreement’ as mandated by a bankruptcy court to buy the assets of Rising Pharmaceuticals. A stalking horse agreement refers to an initial bid for a bankrupt company’s assets and sets the lower limit in a bankruptcy auction.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.

Suven Life Sciences Share Price

169.55 -2.40 (-1.40%)
17-Dec-2025 13:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1793.40
Dr. Reddys Lab 1270.25
Cipla 1495.20
Zydus Lifesciences 918.00
Lupin 2108.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×